Journal of Clinical Endocrinology & Metabolism, Vol 74, 927-933, Copyright © 1992 by Endocrine Society

ARTICLES

Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status

CA Quigley, KJ Friedman, A Johnson, RG Lafreniere, LM Silverman, DB Lubahn, TR Brown, EM Wilson, HF Willard and FS French
Department of Pediatrics, University of North Carolina, Chapel Hill, 27599.

The molecular basis of androgen insensitivity was investigated in a family with the complete form of the syndrome. Polymerase chain reaction amplification and Southern blot analysis of genomic DNA revealed a deletion of the entire androgen receptor (AR) gene in affected individuals. The carrier status of female members of this family was examined using a HindIII restriction fragment length polymorphism associated with the AR gene. Obligate carriers were hemizygous for one of the two alleles at this locus, while heterozygosity for the polymorphic alleles, implying the presence of two copies of the AR gene, indicated noncarrier status. This conclusion was supported by gene dosage studies using comparative densitometric analysis of Southern blots hybridized simultaneously with an AR cDNA probe and a control cDNA probe from an unrelated gene. Finally, the pattern of inheritance of another X-linked DNA polymorphism allowed us to conclude that the original mutation had occurred in the germ line of the maternal great-grandfather of the index patient. Although rare, complete deletion of the AR gene is of particular importance in terms of correlation between molecular defect and phenotype, as it represents the quintessential form of complete androgen insensitivity, the null phenotype.

This article has been cited by other articles:

				H. L. Montie, M. S. Cho, L. Holder, Y. Liu, A. S. Tsvetkov, S. Finkbeiner, and D. E. Merry Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy Hum. Mol. Genet., June 1, 2009; 18(11): 1937 - 1950. [Abstract] [Full Text] [PDF]

				E. S. Chevalier-Larsen, C. J. O'Brien, H. Wang, S. C. Jenkins, L. Holder, A. P. Lieberman, and D. E. Merry Castration Restores Function and Neurofilament Alterations of Aged Symptomatic Males in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy J. Neurosci., May 19, 2004; 24(20): 4778 - 4786. [Abstract] [Full Text] [PDF]

				C. A. Quigley The Postnatal Gonadotropin and Sex Steroid Surge--Insights from the Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 24 - 28. [Abstract] [Full Text] [PDF]

				I. Linfante and T. Ashizawa Proton Magnetic Resonance Spectroscopy: An In Vivo Window to Study Neurodegenerative Disorders Arch Neurol, December 1, 1999; 56(12): 1446 - 1447. [Full Text] [PDF]

				H.T. Orr and H.Y. Zoghbi Toward Understanding Polyglutamine-induced Neurological Disease in Spinocerebellar Ataxia Type 1 Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 649 - 657. [Abstract] [PDF]

				P van der Schoot Foetal testes control the prenatal growth and differentiation of the gubernacular cones in rabbits--a tribute to the late Professor Alfred Jost Development, January 8, 1993; 118(4): 1327 - 1334. [Abstract] [PDF]